TY - JOUR
T1 - Use of poppers and HIV risk behaviours among men who have sex with men in Paris, France
T2 - An observational study
AU - Hambrick, H. Rhodes
AU - Park, Su Hyun
AU - Palamar, Joseph J.
AU - Estreet, Anthony
AU - Schneider, John A.
AU - Duncan, Dustin T.
N1 - Publisher Copyright:
© CSIRO. 2018.
PY - 2018
Y1 - 2018
N2 - The use of inhaled nitrites, or poppers, among men who have sex with men (MSM) is prevalent, yet has been associated with HIV seroconversion. We surveyed 580 MSM from a geosocial networking smartphone application in Paris, France, in 2016. Of the respondents, 46.7% reported popper use within the previous 3 months. Regression models adjusted for sociodemographic characteristics found that the use of poppers was significantly (P < 0.05) associated with the following during the prior 3 months: condomless anal intercourse (adjusted relative risk (aRR) 1.27, 95% confidence interval (CI) 1.07-1.50), use of alcohol and/or drugs during sex once or twice (adjusted relative risk ratio (aRRR) 2.33, 95% CI 1.44-2.03), three to five times (aRRR 5.41, 95% CI 2.98-9.84) or six or more times (aRRR 4.09, 95% CI 2.22-7.56), participation in group sex (aRRR 3.70, 95% CI 2.33-5.90) and self-reported diagnosis with any sexually transmissible infection over the previous year (aRR 1.63, 95% CI 1.18-2.27), specifically chlamydia (aRR 2.75, 95% CI 1.29-4.29) and syphilis (aRR 2.27, 95% CI 1.29-4.29).
AB - The use of inhaled nitrites, or poppers, among men who have sex with men (MSM) is prevalent, yet has been associated with HIV seroconversion. We surveyed 580 MSM from a geosocial networking smartphone application in Paris, France, in 2016. Of the respondents, 46.7% reported popper use within the previous 3 months. Regression models adjusted for sociodemographic characteristics found that the use of poppers was significantly (P < 0.05) associated with the following during the prior 3 months: condomless anal intercourse (adjusted relative risk (aRR) 1.27, 95% confidence interval (CI) 1.07-1.50), use of alcohol and/or drugs during sex once or twice (adjusted relative risk ratio (aRRR) 2.33, 95% CI 1.44-2.03), three to five times (aRRR 5.41, 95% CI 2.98-9.84) or six or more times (aRRR 4.09, 95% CI 2.22-7.56), participation in group sex (aRRR 3.70, 95% CI 2.33-5.90) and self-reported diagnosis with any sexually transmissible infection over the previous year (aRR 1.63, 95% CI 1.18-2.27), specifically chlamydia (aRR 2.75, 95% CI 1.29-4.29) and syphilis (aRR 2.27, 95% CI 1.29-4.29).
KW - HIV prevention
KW - STIs
KW - substance use
UR - http://www.scopus.com/inward/record.url?scp=85049257055&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049257055&partnerID=8YFLogxK
U2 - 10.1071/SH17217
DO - 10.1071/SH17217
M3 - Article
C2 - 29852927
AN - SCOPUS:85049257055
SN - 1448-5028
VL - 15
SP - 370
EP - 373
JO - Sexual Health
JF - Sexual Health
IS - 4
ER -